The extracellular calcium-sensing receptor (CaSR) plays a pivotal role in the regulation of extracellular calcium such that abnormalities, which result in a loss or gain of function, lead to hypercalcemia or hypocalcemia, respectively, in patients. Mice carrying CaSR knockout alleles develop hypercalcemia that mimics the disorders observed in humans. To date, there is no mouse model for an activating CaSR mutation. Here, we describe such a mouse model, named Nuf, originally identified for having opaque flecks in the nucleus of the lens in a screen for eye mutants. Nuf mice also display ectopic calcification, hypocalcemia, hyperphosphatemia, and inappropriately reduced levels of plasma parathyroid hormone. These features are similar to those observed in patients with autosomal dominant hypocalcemia. Inheritance studies of Nuf mice revealed that the trait was transmitted in an autosomal-dominant manner, and mapping studies located the locus to chromosome 16, in the vicinity of the CaSR gene (Mouse Genome Database symbol Gprc2a). DNA sequence analysis revealed the presence of a Gprc2a missense mutation, Leu723Gln. Transient expression of wild-type and mutant CaSRs in human embryonic kidney 293 cells demonstrated that the mutation resulted in a gain of function of the CaSR, which had a significantly lower EC 50. Thus, our results have identified a mouse model for an activating CaSR mutation, and the development of ectopic calcification and cataract formation, which tended to be milder in the heterozygote Nuf mice, indicates that an evaluation for such abnormalities in autosomal dominant hypocalcemia patients who have activating CaSR mutations is required.
T he extracellular calcium-sensing receptor (CaSR) Online Mendelian Inheritance in Man (OMIM) accession no. 601199 is a plasma membrane-bound protein that is predominantly expressed in the parathyroids and kidneys, where it regulates parathyroid hormone (PTH) secretion and renal tubular calcium reabsorption appropriate to the prevailing extracellular calcium concentration ([Ca 2ϩ ] o ) (1) (2) (3) (4) . The CaSR is also expressed in other tissues that include the thyroid, intestine, bone, bone marrow, brain, skin, lens epithelium, pancreas, lung, and heart, where its function remains to be defined (1) . The CaSR is a member of family C of the superfamily of G proteincoupled receptors that includes the metabotrophic glutamate receptors, some pheromone receptors, and the ␥-amino butyric acid receptors (1, 5) . Ligand binding by the CaSR results in G protein-dependent stimulation, mediated by Gq͞11, of phospholipase C activity causing an accumulation of inositol 1,4,5-trisphosphate and rapid release of calcium ions from intracellular stores. This release is followed by an influx of extracellular calcium ions (1) (2) (3) . The increase in intracellular calcium results in activation of phosphokinase C, which in turn activates the mitogen-activated protein kinase (MAPK) pathway (1, 6) . The CaSR can also activate the MAPK pathway through an isoform of Gi that inhibits adenylate cyclase and that activates Src-family tyrosine kinases (1, 6) . The manner in which these intracellular events regulate parathyroid cell proliferation and the rate of PTH secretion from the parathyroid cell, together with the reduction in renal tubular calcium reabsorption, remains to be elucidated. However, much has been learned about the role of the CaSR in the regulation of extracellular calcium homeostasis by the identification of CaSR mutations in human disorders (www.casrdb.mcgill.ca) and by studies of CaSR knockout mice (7) . In man, inactivating CaSR mutations result in familial (benign) hypocalciuric hypercalcemia (FBHH), OMIM accession no. 145980, and neonatal severe primary hyperparathyroidism (NSHPT), OMIM accession no. 239200 (8, 9) , whereas activating CaSR mutations result in autosomal dominant hypocalcemia (ADH), OMIM accession no. 601198 (10, 11) , which may be sometimes associated with hypercalciuria and a Bartterlike syndrome (12, 13) . Furthermore, mice heterozygous for a CaSR knockout allele mimic the phenotype of FBHH patients with modest elevations in serum calcium and relative hypocalciuria, whereas homozygous mice exhibit a phenotype similar to NSHPT, with severe hypercalcemia, parathyroid hyperplasia, bone abnormalities, and neonatal death (14) . The understanding of the manner in which the CaSR exerts these effects would be greatly enhanced by the availability of a mouse model with an activating CaSR mutation. Here, we describe such a model that bears the mutation Gprc2a Nuf (which will be referred to as Nuf ). The founder animal was identified by screening mouse mutants that were generated by use of the mutagenic alkylating chemical, isopropyl methane sulfonate (15, 16) .
Materials and Methods
Experimental Animals. All studies were performed under the guidance issued by the Medical Research Council and Home Office Project license nos. 30͞1517 and 30͞2049. Mouse lines were housed on site in a controlled environment and were sustained on expanded rat and mouse no. 3 breeding diet (Special Diets Services, Witham, Essex, U.K.) containing 1.15% calcium, 0.82% total phosphorus, and 4088.68 units͞kg vitamin D.
Generation of Mutant Mice. The original mutant animal, known as iPMS-112, was found in a mutagenesis experiment at the Institute of Mammalian Genetics (Neuherberg, Germany), in which males of genotype (C3H͞He ϫ 102͞El)͞F1͞(the 102 stock is thought to have arisen from a cross of strain 101 with C3H) were treated with isopropyl methane sulfonate and bred so that spermatogonial stem cells were sampled. The offspring were scored for cataracts (16) . The animal iPMS-112 had ''nuclear flecks'' in the lens. When crossed with a normal mouse, it produced offspring with a similar phenotype, indicating autosomal dominant inheritance. The mutant was transferred to Medical Research Council Harwell (Oxfordshire, U.K.) for further studies and given the name ''nuclear flecks'' and symbol Nuf.
Phenotype Screen. Mice aged 4-6 weeks were phenotyped for presence of opaque flecks in the lens nucleus by slit lamp biomicroscopy (Zeiss 30SL͞M) at ϫ20 magnification with a narrow beam slit lamp illumination at a 25-30°angle from the direction of observation. Dilation of the pupil was achieved with 1% atropine sulfate (Schering-Plough) applied at least 10 min before examination.
Animals for Further Studies. Animals for histology and biochemistry were obtained from a homozygous breeding stock of Nuf͞Nuf with a background of strains C3H and 102. For normal controls the inbred strain 102͞H was used and heterozygous Nuf͞ϩ animals were obtained by crossing Nuf͞Nuf ϫ 102͞H.
Mapping. Nuf͞ϩ mice were crossed to C57BL͞6 and affected offspring were backcrossed to C3H͞HeH. Backcross offspring were scored for cataract and were then typed for microsatellite markers spaced at Ϸ20-cM intervals throughout the genome, which can be accessed at www.informatics.jax.org. DNA was extracted from tail tissues by using Nucleon Biosciences genomic DNA extraction kits (Amersham Biosciences, Piscataway, NJ) (Nucleon HT protocol for hard tissues). Any areas of potential linkage were expanded by the inclusion of additional markers in that region. PCR conditions were described (17) .
Biochemical Analysis. All samples were collected from mice that were allowed to eat and drink ad libitum. Samples were not collected from breeding pairs or lactating females. Blood samples were collected from the lateral tail vein from groups of mice (age Ϸ120 days, n ϭ 7-10 for each sex and genotype) as described (18) . Urine samples (from the same cohorts) were collected into Eppendorf tubes and frozen at Ϫ70°C until analysis. Plasma and urine samples were analyzed for calcium, phosphate, creatinine, sodium, potassium, chloride, magnesium, and bicarbonate by using an Abbott Aeroset analyzer. Urine parameters were calculated relative to sample creatinine. Plasma PTH concentration was measured (age Ϸ90 days, n ϭ 4-5 for each cohort) by using a commercial ELISA specific for mouse intact PTH (Immutopics, San Clemente, CA) with a detection limit of 0.5 pmol͞liter. All statistical analyses were performed in Microsoft Excel.
Pathology. Male and female Nuf͞Nuf, Nuf͞ϩ, and 102͞H controls (age range 116-430 days) were examined by gross post mortem and histology. The primary objective was to evaluate the extent of ectopic mineralization and to determine parathyroid tissue status in Nuf͞Nuf and Nuf͞ϩ mice. Mice were killed by a barbiturate overdose administered i.p. The lungs were inflated with 10% neutral buffered formalin (NBF), leaving the heart attached to avoid accidental lung puncture. All tissues were fixed in 10% NBF with the exception of testes that were fixed in Bouin's solution and the eyes in Davidson's solution. Bony tissues were decalcified in 10% formic acid. After decalcification, cross and longitudinal sections of lumbar vertebral column and three cross sections of snout were cut. The remainder of the head was embedded and sectioned in dorsal plane to examine the middle ear. The brain was fixed for 48 h in NBF and four coronal slices were cut at the level of the rostral olfactory cortex, thalamus, midbrain, and cerebellum͞brainstem. After processing to wax, 4-m sections were cut and stained with hematoxylin͞ eosin. Selected sections were stained by Von Kossa's method for calcium. Faxitron digital x-ray images of selected NBF-fixed tongues were made to assess the macroscopic pattern of soft tissue mineralization before histological processing.
DNA Sequence Analysis. DNA was extracted from mouse kidney by using a Puregene DNA isolation kit (Gentra Systems). Fourteen pairs of primers (details available on request) were used for the PCR amplification of the seven exons and 12 intron-exon boundaries of Gprc2a (the mouse orthologue of the human CaSR). The DNA sequences of both strands were determined as described (19) and were resolved on a semiautomated 377 sequencer detection system (Applied Biosystems). DNA sequence abnormalities in the Nuf mice were confirmed by PstI restriction endonuclease analysis (New England Biolabs) as described (11) .
Functional Expression of CaSR. Functional studies were performed by using a human CaSR cDNA construct (20) because the human and mouse CaSR amino acid sequences are 92% identical and are 100% identical in the region surrounding the mutated site. The reported pcDNA3-CaSR construct (11) was subcloned into the pEGFP-N2 vector (BD Biosciences Clontech, Palo Alto, CA) and the Q723 mutation was introduced by site-directed mutagenesis (QuikChange, Stratagene) as reported (21) . The wild-type and mutant CaSRs were transiently transfected into human embryonic kidney (HEK)293 cells (American Type Culture Collection catalog no. CRL1573) by using Lipofectamine Plus (Invitrogen) as described (20) . Cells were visualized by using a Nikon Eclipse E400 microscope with a Y-FL Epifluorescence attachment and a triband 4Ј,6-diamidino-2-phenylindole-FITC-Rhodamine filter, as reported (21) . Expression of CaSR-EGFP fusion proteins was also confirmed by Western blot analysis of cellular protein extracts using an antibody to GFP (Santa Cruz Biotechnology) as reported (21) .
The wild-type and mutant CaSRs were functionally assessed by measuring the alterations in intracellular calcium concentration ([Ca 2ϩ ] i ) in response to changes in [Ca 2ϩ ] o as follows. Forty-eight hours posttransfection, the cells were harvested, washed twice in Ca-and Mg-free Hanks' balanced salt solution (HBSS) (Invitrogen), and loaded with 1 g͞ml indo-1 acetoxymethylester (Molecular Probes) for 1 h at 37°C. After removal of free dye by centrifugation and washing with Ca-and Mg-free HBSS, the cells were resuspended in 1 ml of Ca-and Mg-free HBSS and maintained at 37°C. Flow-assisted cell sorting was performed with a Cytomation MoFlo flow cytometer (DakoCytomation, Carpenteria, CA) equipped with an argon laser (Coherent Radiation, Palo Alto, CA) as described (22, 23) . Baseline fluorescence ratio was measured for 2 min, the fluorescence ratio versus time was recorded, and data were collected for 2 min at each [Ca 2ϩ ] o . Cytomation SUMMIT software was used to determine the peak mean fluorescence ratio of the transient response after each individual stimulus and normalized response. [Ca 2ϩ ] o curves were generated as described (20) . EC 50 (i.e., [Ca 2ϩ ] o required for 50% of the maximal response) for each normalized concentration-response curve was determined, and the mean EC 50 for six separate transfection experiments was used for statistical comparison by using Student's t test.
Results
The founder animal was identified by having opaque flecks in the nucleus of the eye lens in a screen for new eye mutants. Subsequent histological and biochemical investigations revealed that the cataracts constituted only a minor part of the phenotype, which also included ectopic calcification, hypocalcemia, hyperphosphatemia, inappropriately reduced levels of plasma PTH, and sudden death.
Inheritance Studies. In all of the breeding studies, the phenotype of the animals was determined by slit lamp examination for cataracts. Nuf͞ϩ heterozygotes were crossed with normal C3H͞ HeH or 102͞H control animals, and crosses of Nuf͞ϩ ϫ Nuf͞ϩ were made to detect homozygous Nuf͞Nuf ( Table 1 ). The cataract phenotype of heterozygotes was very mild (Fig. 1B) and classification as normal or affected was difficult. A few mice scored as affected bred as if in fact normal. It is reasonable to suppose that also a few Nuf͞ϩ mice were wrongly scored as normal. Among the offspring of Nuf͞ϩ ϫ Nuf͞ϩ, some animals were more severely affected, suggesting that they might be homozygotes. This result was confirmed by crosses of affected offspring of intercrosses to normal to detect those that produced affected young only. Of 21 young tested, 2 bred as Nuf͞Nuf and 2 of 7 young of Nuf͞Nuf ϫ Nuf͞ϩ also bred as Nuf͞Nuf. From these mice, a homozygous breeding stock of Nuf͞Nuf was set up. The cataracts of the Nuf͞Nuf mice were in general more severe than those of Nuf͞ϩ, but there was overlap in severity of phenotype, and it was not possible to score animals as Nuf͞Nuf or Nuf͞ϩ by cataract phenotype alone ( Fig. 1 A-C) . The ratio of affected to normal young among offspring of Nuf͞ϩ ϫ Nuf͞ϩ was significantly Ͻ3:1 ( 2 ϭ 7.61, df ϭ 1, P Ͻ 0.01) and the proportion of affected offspring that bred as Nuf͞Nuf was also less than the expected one-third, although not significantly so. Possible explanations for this result include misclassification of Nuf͞ϩ young as ϩ͞ϩ and Nuf͞Nuf young as Nuf͞ϩ, or the death of some Nuf͞Nuf before classification.
The cataracts consisted of a group of small opaque dots in the lens nucleus. In homozygotes, the dots were larger and more numerous than in heterozygotes ( Fig. 1 A-C) . The cataracts were present at 4-6 weeks of age. Some animals were observed up to Ϸ1 year of age and the cataracts did not appear to increase in severity. However, in homozygotes, scattered corneal opacities were evident at later ages and these appeared to worsen.
A proportion of Nuf͞Nuf breeding mice, mainly lactating females, died suddenly. In one 12-month period, of a total of 31 mated females and 16 males, 15 females and 4 males were found dead. At the time of death, 11 females were lactating with their first to third litters. Over the same time period, and in the same animal room, 11 pairs of the 102͞H control strain, and 16 females and 8 males of a different cataract strain were mated and no deaths were observed. The affected Nuf͞Nuf animals appeared healthy and were found dead the next day, without any intervening illness. At necropsy, no gross abnormalities were seen, but on histological analysis, foci of calcification were observed in various tissues.
Biochemical Phenotypes. The male and female Nuf͞ϩ and Nuf͞ Nuf mice had significant hypocalcemia and hyperphosphatemia that was associated with inappropriately reduced plasma PTH levels ( Table 2) . No significant differences were observed in plasma and urinary magnesium. Normal plasma magnesium in the mutant mice indicated that hypomagnesemia was not a secondary cause for impaired PTH secretion. The Nuf͞ϩ and Nuf͞Nuf mice did not have significantly elevated urinary excretion of calcium and phosphate, although the Nuf͞Nuf females were hypocalciuric and both Nuf͞Nuf males and females were hypophosphaturic (Table 2) . Additional biochemical data for plasma bicarbonate and plasma and urinary sodium, potassium and chloride is provided in Table  4 , which is published as supporting information on the PNAS web site. (Table 3 ). Although the mice of different genotypes were not precisely age-matched, the age range in each group overlapped. Mineralization was seen consistently in the youngest Nuf͞Nuf mice examined at Ϸ130 days and, with the exception of the reproductive tract, heart, and kidney tubules, there was no comparable mineralization in Nuf͞ϩ mice up to Ϸ350 days old. In comparison with another inbred strain, C3H, that is predisposed to soft tissue mineralization, the incidence of mineralization at the two most common sites in Nuf͞Nuf mice, the vibrissa dermal sheath (88%) and tongue (97%), was more than twice that in a similar aged group of C3H mice (33% and 40%, respectively). In the tongue, mineralization was accompanied by localized histiocytic reaction, but in other tissues there was no localized inflammatory reaction. The clinical significance of vascular mineralization is uncertain, but there was no evidence of ischemic injury to the tissues that the blood vessels supply. Micronodular soft tissue mineralization was evident in x-ray images in the midlateral regions of the tongue (Fig. 1D) , and this result corresponded to basophilic concretions in hematoxylin͞ eosin sections (Fig. 1E) . The calcium component of larger mineralized concretions in the tongue and intestine smooth muscle (Fig. 1F ) was confirmed by Von Kossa's staining (data not shown), but in small deposits in the vibrissa dermal sheath (Fig. 1G) , Von Kossa's staining was weak or absent. Vascular mineralization is common in testis artery and renal artery and capillaries ( Fig. 1 H-J) . The ocular pathology findings confirmed that the nuclear flecks in Nuf͞Nuf mice were small cataracts comprised of foci of lens fiber swelling and degeneration without a significant degree of mineralization. In a few cases, there were also small foci of corneal mineralization (data not shown). Serial cross sections of the thyroids of selected Nuf͞Nuf mice confirmed histologically normal bilateral parathyroids were present in all cases. Single sections confirmed the presence of parathyroid tissue in other cases.
Chromosomal Localization of Nuf Locus. Preliminary results by using informative markers showed significant linkage of the phenotype to D16Mit131 ( 2 ϭ 8.26, df ϭ 1, P Ͻ 0.01; data not shown). The same sets of animals were then typed with further chromosome 16 markers. Some animals gave anomalous results, suggesting that they were misclassified for Nuf and these results were excluded. Results from the remaining 53 mice indicated that the Nuf locus lies distal to D16Mit88 and proximal to markers D16Mit103 and D16Mit134. The recombination percentages were D16Mit131Ϫ3.8 Ϯ 2.6ϪD16Mit88Ϫ7.6 Ϯ 3.6ϪNufϪ7.6 Ϯ 3.6Ϫ(D16Mit103, D16Mit134)Ϫ3.8 Ϯ 2.6ϪD16Mit88Ϫ1.9 Ϯ 1.9ϪD16Mit173Ϫ7.6 Ϯ 3.6ϪD16Mit189. This result placed the Nuf locus near position 18 cM, thus making Gprc2a (coding for the CaSR) a candidate gene.
Identification of the Mutation in Gprc2a (the Mouse CaSR) and Its
Functional Characterization. Analysis of the DNA sequence of the entire 3,234-bp coding region and of the 810 bp of the two 5Ј-noncoding exons of Gprc2a revealed a homozygous missense (14) 1͞6 (17) Data in the body of the table are reported as positive cases͞number of mice examined and percent positive in parentheses. Less frequent sites of ectopic mineralization include eye retinal pigmented epithelium and cornea, ear spiral ganglion, and trigeminal ganglion. The pituitary, thyroids, and parathyroids, trachea, pancreas, liver, adrenals, spleen, sciatic nerve, skin samples from the dorsum and ventrum, lumbar vertebral column, knee joint, tail, foot, and middle ears were also examined but were not found to be sites of ectopic calcification. Ocular findings included small foci of corneal mineralization in Nuf͞Nuf mice and cataracts (see text for details). The numbers of mice examined, their age range, and ages of individual mice are provided separately in Data Set 1, which is published as supporting information on the PNAS web site. mutation in the fourth transmembrane domain of the receptor in the Nuf͞Nuf mice ( Fig. 2A) . This mutation, which consisted of a T-to-A transversion (CTG to CAG) at codon 723, predicted the substitution of an evolutionary conserved Leu (L) by a Gln (Q) residue (Fig. 2B) . The mutation was associated with the loss of a PstI restriction enzyme site, which facilitated its detection (Fig.  2C) . Nuf͞Nuf mice were homozygous for the Q723 mutation, Nuf͞ϩ mice were heterozygous (L͞Q723), and control 102͞H mice were homozygous for L723. Functional expression of the wild-type and mutant CaSRs was undertaken by using HEK293 cells (Fig. 3) . The mutant and wild-type CaSR were both expressed mainly at the plasma membrane and in the cytoplasm but not in the nucleus (Fig. 3 A-C) . Western blot analysis confirmed expression of the mutant and wild-type CaSRs as 167-kDa proteins (Fig. 3D) , which consisted of the 140-kDa CaSR tagged with a 27-kDa enhanced GFP (EGFP). A functional characterization of the wild-type and mutant CaSRs, as assessed by the alteration in [Ca 2ϩ ] i in response to [Ca 2ϩ ] o , revealed the mutant CaSR to have a significantly (P Ͻ 0.01) lower EC 50 (1.95 mM Ϯ 0.12) when compared with the EC 50 of the wild type (2.25 Ϯ 0.07) (Fig. 3E) . Thus, the mutant CaSR showed a significant leftward shift in its concentration-response curve when compared with the wild type, thereby demonstrating that the mutant CaSR is active at a lower [Ca 2ϩ ] o than the wild type, which is consistent with it being an activating mutation of the Gprc2a gene.
Discussion
Our studies have identified a mutant mouse line (Nuf) with an activating CaSR mutation that results in hypocalcemia, hyperphosphatemia, cataracts, and ectopic calcification (Fig. 1) . The data provide strong evidence that the mutation in the mouse CaSR gene (Gprc2a) underlies the observed phenotypic effects. The amino acid substitution observed in the Nuf mice is unlikely to be a silent polymorphism, because the leucine residue altered is highly conserved among species (Fig. 2) . The alteration from a leucine residue, which is nonpolar and hydrophobic, to a polar and hydrophyllic glutamine residue, leads to a functional change as demonstrated by the transient transfection experiments in which cells transfected with a Nuf mutant CaSR show an increase in sensitivity to calcium ions, as expected for an activating mutation (Fig. 3) . Certain phenotypic abnormalities were more pronounced in Nuf͞Nuf mice than in Nuf͞ϩ mice, which suggests a dosage effect of the mutated allele. However, this result was not the case for all of the parameters investigated.
Nuf͞ϩ mice have similarities to ADH patients with heterozygous activating CaSR mutations, including hypocalcemia, hyperphosphatemia, and inappropriately low plasma PTH concentrations (Table 2 and ref. 11). However, there are also important differences. The Nuf͞ϩ and Nuf͞Nuf mice are not hypercalciuric, whereas patients with activating CaSR mutations have an elevated urinary calcium excretion that increases with vitamin D supplementation (1, 11, 24) . The vitamin D content of the diet (24, 25) may not have been sufficient to render the Nuf͞ϩ and Nuf͞Nuf mice hypercalciuric. Additional studies of these mice by using metabolic cages for 24-h urine collection, which are more reliable than the spot collections used in the present study (11) , are required to further characterize the effects of the Q723 mutation in the CaSR on the renal handling of calcium and phosphate.
The Nuf͞ϩ and Nuf͞Nuf mice developed cataracts and a heightened incidence of ectopic calcification at all of the common noncardiac sites reported in mice (26) (Table 3 and Fig. 1 ). Cataracts and ectopic calcification have not been reported in ADH patients with activating CaSR mutations. These features are milder in the heterozygous Nuf͞ϩ mice, and thus it is possible that in ADH patients, who are heterozygous for CaSR mutations, such mild abnormalities may not have been symptomatic and therefore may not have been detected. However, soft tissue calcification has been reported in some ADH patients (11) . For example renal calcification has been reported in Ͼ50% of ADH patients and basal ganglia calcification in 10%. The mechanisms underlying such calcifications are not known, but the identification of CaSR expression in the lens epithelial cells (27) ] i triggers the activation of calpain, which in turn modifies the cytoskeletal proteins and a ␤-crystallin in lens cataract models (28, 29) . Moreover, the lens possesses a large array of G protein receptors that are coupled to the release of Ca 2ϩ (30, 31) , including CaSR, which has been shown to be expressed in human lens epithelial cells (27) . Thus, it is possible that the Q723 mutant CaSR of the Nuf͞ϩ and Nuf͞Nuf mice results in activation at a lower [Ca 2ϩ ] o (Fig. 3) , which in turn activates phospholipase C ␤ that mobilizes inositol 1,4,5-trisphosphate and releases Ca 2ϩ from intracellular stores. The rise in [Ca 2ϩ ] i will in turn activate calpain, which will lead to a modification of the cytoskeletal proteins that are known to be altered in lens cataracts models. This model for cataract formation, based on the observations of the activating CaSR mutation of the Nuf mice, may also apply to the occurrence of ectopic calcification at other sites where the CaSR is expressed. Our results on the Nuf͞ϩ and Nuf͞Nuf mice also indicate that an evaluation for ectopic calcification and cataract formation in ADH patients is required.
